|
|
|
|
|
|
 |
|
|
|
 |
|
Accelitech secures $30 million financing commitment from MarCap to support new venture growth Rosemont, Illinois - January 10, 2006 - Accelitech LLC, a developer of physician and hospital joint ventures, announced today that it has secured a $30 million dollar equipment financing facility from MarCap Corporation. MarCap’s capital will be available to back Accelitech’s joint ventures to acquire stereotactic radiosurgery and advanced image-guided radiation therapy systems for cancer treatment centers. These Technology systems include the Accuray CyberKnife®, Varian Medical System Trilogy®, Elekta Gamma Knife® and Elekta Synergy®, BrainLab Novalis® and TomoTherapy®. "We are thrilled to have MarCap as our financial partner," said Kerwin Brandt, CEO of Accelitech. "Their commitment facilitates Accelitech in rapidly converting our strong pipeline into successful joint ventures. Accelitech’s partnership with MarCap comes on the heels of our recent closing of working capital financing, and places Accelitech in an excellent position to execute on this market opportunity." "Accelitech provides a much needed solution to the healthcare industry and their management has the experience to successfully structure and manage these ventures," says Brad Stern, Regional Vice President of MarCap. "Our funding commitment reflects our confidence that Accelitech can partner with hospitals and physicians to create many successful regional cancer treatment programs built around stereotactic radiosurgery technologies. We are excited to help Accelitech bring these new treatment technologies to communities throughout the U.S." About Accelitech LLC About MarCap Corporation MarCap is a member of The Marmon Group of companies, an international association of more than 100 companies that operate independently within diverse business sectors. Member companies have collective sales of approximately $6 billion.
|
|
|
|